+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Coronary Artery Disease Treatment Devices Market by Device Type, Treatment Type, Approach, End User - Global Forecast to 2030- Product Image
Coronary Artery Disease Treatment Devices Market by Device Type, Treatment Type, Approach, End User - Global Forecast to 2030- Product Image
Sale

Coronary Artery Disease Treatment Devices Market by Device Type, Treatment Type, Approach, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 193 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4989780
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Coronary Artery Disease Treatment Devices Market grew from USD 4.58 billion in 2024 to USD 4.84 billion in 2025. It is expected to continue growing at a CAGR of 5.78%, reaching USD 6.41 billion by 2030.

Revolutionizing Coronary Care with Precision Devices

Coronary artery disease continues to present significant challenges for healthcare systems worldwide, driving a critical need for innovative treatment devices that enhance patient outcomes. Advances in interventional cardiology have transformed the management of arterial blockages, positioning device-based therapies at the forefront of clinical practice. Precision-engineered stents and atherectomy systems offer targeted approaches to restoring vessel patency, while cutting-edge imaging and guidewire technologies deliver real-time insights that optimize procedural success. This executive summary delves into the competitive landscape, capturing key technological advancements and strategic imperatives that are reshaping the coronary device market.

In response to rising prevalence rates and evolving patient profiles, device manufacturers are intensifying research and development efforts to address increasingly complex lesions and comorbidities. Regulatory agencies have streamlined approval pathways for next-generation platforms, accelerating the transition from concept to clinical implementation. Simultaneously, healthcare providers are demanding evidence-based solutions that demonstrate both safety and long-term efficacy. This report synthesizes these converging forces to provide decision-makers with a clear understanding of current market dynamics, enabling them to anticipate shifts and capitalize on emerging opportunities.

Emerging Dynamics Redefining Coronary Treatment Landscape

The coronary treatment landscape has entered a transformative era defined by a confluence of technological breakthroughs and shifting clinical paradigms. Minimally invasive approaches have gained traction, driven by patient preference for shorter recovery times and reduced procedural risks. Optical coherence tomography and intravascular ultrasound systems now offer unprecedented clarity in lesion assessment, guiding the deployment of stents and atherectomy devices with micrometer-level precision. Furthermore, drug-eluting scaffolds and bioresorbable platforms are redefining long-term vessel healing, minimizing restenosis rates and improving quality of life.

Regulatory reforms have further accelerated innovation, as agencies adopt adaptive frameworks that balance patient safety with expedited access to breakthrough technologies. The integration of digital health platforms and artificial intelligence into procedural workflows is catalyzing a new generation of decision-support tools, enabling clinicians to personalize device selection and treatment strategies. As stakeholder expectations evolve, manufacturers are forging strategic collaborations and leveraging data-driven insights to refine product portfolios, ensuring that tomorrow’s devices address the most pressing clinical challenges.

Assessing the Ripple Effects of 2025 US Tariffs on Device Access

The implementation of new tariff schedules by the United States in 2025 has introduced a complex set of cost dynamics for coronary device manufacturers and healthcare providers. Increased import duties on key components have exerted upward pressure on production expenses, prompting firms to reassess supply chain footprints and sourcing strategies. Some manufacturers have responded by relocating assembly operations closer to end markets or by negotiating local manufacturing partnerships to mitigate tariff-induced margins.

Healthcare institutions are similarly adapting procurement practices to balance budget constraints with clinical imperatives. In many cases, providers are engaging in collaborative purchasing agreements and exploring alternative device portfolios that preserve quality standards while dampening cost exposure. Concurrently, regional distributors are expanding inventory buffers and renegotiating vendor contracts to ensure consistent access to critical platforms. These collective efforts underscore the industry’s resilience and capacity for strategic adaptation in the face of evolving trade policies.

Unveiling Market Segmentation Patterns Driving Strategic Decisions

A nuanced understanding of market segmentation reveals that growth trajectories vary significantly across device type, treatment modality, procedural approach, and end user setting. Within interventional platforms, the precision offered by atherectomy technologies-ranging from laser and orbital to rotational modalities-has garnered particular interest among specialists treating heavily calcified lesions. At the same time, the demand for balloon catheters spans from cutting-edge drug-coated and cutting variants to reliable standard configurations, reflecting a spectrum of lesion characteristics and clinical preferences.

Intravascular imaging systems have become indispensable diagnostic adjuncts, with frictional flow reserve, ultrasound, and optical coherence platforms each contributing unique insights to procedural planning. Likewise, stent selection continues to evolve as clinicians weigh the benefits of bare metal structures, bioresorbable scaffolds, and advanced drug-eluting designs. The choice between surgical bypass and percutaneous interventions hinges on patient risk profiles and lesion complexity, whether off-pump or on-pump grafting or angioplasty versus stenting. Additionally, the shift toward transradial over transfemoral access underscores a drive for reduced complication rates and enhanced patient comfort. Hospitals, cardiac specialty centers, and ambulatory surgical facilities each present distinct procedural volumes and purchasing cycles, shaping the adoption curve for specific device categories.

Regional Nuances Shaping Global Coronary Device Adoption

Regional dynamics exert a profound influence on device adoption, reimbursement frameworks, and clinical practice standards. In the Americas, well-established healthcare infrastructures and favorable reimbursement policies support the uptake of premium device offerings, while patient advocacy groups and professional societies actively shape best-practice guidelines. Conversely, Europe, the Middle East, and Africa present a tapestry of regulatory regimes and funding mechanisms, where cross-border harmonization efforts coexist with localized tender processes and competitive concession models.

Asia-Pacific markets are characterized by burgeoning patient populations and expanding access to interventional cardiology, propelled by investments in healthcare modernization and skill development programs. Emerging economies in this region are increasingly prioritizing indigenous production capabilities, fostering government incentives that encourage domestic device manufacturing. Taken together, these regional insights highlight the importance of tailoring market entry strategies and engagement models to the specific reimbursement landscapes, clinical education needs, and procurement cycles of each geography.

Competitive Footprint and Innovation Trajectories of Leading Players

Leading device manufacturers are differentiating themselves through targeted investments in research and development, strategic alliances, and portfolio diversification. Firms with robust pipelines in bioresorbable stent platforms and advanced imaging modalities are securing prime positions in high-growth segments. Companies with extensive global distribution networks and localized production facilities enjoy resilience against supply chain disruptions and tariff fluctuations, while those prioritizing digital tool integration are setting new benchmarks for procedural efficiency.

Collaborative agreements between device innovators and academic institutions have accelerated clinical validation and post-market surveillance, yielding real-world data that informs iterative product enhancements. Meanwhile, mid-sized enterprises are leveraging agility to introduce niche technologies that address underserved lesion types or procedural pain points. The competitive landscape thus comprises a balance of established market leaders fostering incremental innovation and emerging challengers pursuing disruptive clinical solutions.

Strategic Imperatives for Industry Leaders to Secure Growth

Industry leaders must embrace a multifaceted strategy that aligns product innovation with operational agility and stakeholder collaboration. Prioritizing modular manufacturing capabilities will enable swift responses to tariff-induced cost pressures and evolving regulatory demands. Simultaneously, investing in digital platforms that integrate imaging data with predictive analytics can enhance procedural planning and support value-based reimbursement models.

Establishing partnerships with centers of excellence and conducting focused clinical studies will generate the evidence base needed to differentiate next-generation devices. Cultivating robust training programs for interventionalists and support staff ensures seamless adoption and optimizes procedural outcomes. Moreover, a balanced portfolio approach-spanning premium and cost-effective device tiers-will maximize market penetration across diverse healthcare settings. By executing these strategic imperatives, companies can fortify their competitive positioning and drive sustained growth in an increasingly complex marketplace.

Robust Methodology Underpinning the Comprehensive Market Study

This market study synthesizes insights garnered through a rigorous combination of primary and secondary research methodologies. In-depth interviews with key opinion leaders, procurement specialists, and clinical experts were conducted to capture firsthand perspectives on procedural trends, device performance expectations, and purchasing dynamics. Complementary secondary research encompassed analysis of regulatory filings, corporate financial disclosures, and peer-reviewed publications to validate market developments and technological advancements.

Data triangulation techniques were employed to reconcile insights from multiple sources, ensuring the robustness and reliability of segmentation assumptions and company profiles. The research framework encompasses an exhaustive mapping of device classifications, treatment categories, procedural approaches, and end user landscapes, all contextualized within regional healthcare environments. Quality assurance measures, including internal peer reviews and cross-functional validation, underpin the integrity of the findings presented herein.

Synthesis of Critical Findings and Future Outlook for Coronary Devices

The convergence of technological innovation, evolving clinical protocols, and shifting trade policies has created a dynamic environment for coronary artery disease treatment devices. Precision interventional platforms, from atherectomy systems to bioresorbable stents, are redefining procedural efficacy, while advanced imaging and guidewire solutions enhance decision-making at every stage. The 2025 tariff adjustments have underscored the importance of supply chain resilience and strategic localization, prompting industry stakeholders to adopt flexible manufacturing and procurement models.

Segmentation analysis reveals that market opportunities are nuanced by device type, treatment modality, procedural approach, and healthcare setting, each demanding tailored engagement strategies. Regional insights highlight divergent reimbursement frameworks and adoption rates across the Americas, EMEA, and Asia-Pacific, emphasizing the necessity of adaptable market entry tactics. Competitive dynamics continue to evolve as established players and nimble challengers alike invest in R&D collaborations, digital integration, and evidence generation. Collectively, these insights form a cohesive narrative that equips decision-makers with the knowledge to anticipate market shifts and drive innovation.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Device Type
    • Atherectomy Device
      • Laser Atherectomy
      • Orbital Atherectomy
      • Rotational Atherectomy
    • Balloon Catheter
      • Cutting Balloon Catheter
      • Drug-Coated Balloon Catheter
      • Standard Balloon Catheter
    • Guidewire
      • Polymer-Jacketed
      • PTFE-Coated
      • Untreated
    • Intravascular Imaging System
      • Fractional Flow Reserve
      • Intravascular Ultrasound
      • Optical Coherence Tomography
    • Stent
      • Bare Metal Stent
      • Bioresorbable Scaffold
      • Drug Eluting Stent
  • Treatment Type
    • Coronary Artery Bypass Grafting
      • Off Pump
      • On Pump
    • Percutaneous Coronary Intervention
      • With Balloon Angioplasty
      • With Stenting
  • Approach
    • Transfemoral Approach
    • Transradial Approach
  • End User
    • Ambulatory Surgical Centers
    • Cardiac Centers
    • Hospitals
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Medtronic plc
  • Terumo Corporation
  • Biotronik SE & Co. KG
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Meril Life Sciences Pvt. Ltd.
  • OrbusNeich Medical Company Limited
  • MicroPort Scientific Corporation
  • Cardinal Health, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Coronary Artery Disease Treatment Devices Market, by Device Type
8.1. Introduction
8.2. Atherectomy Device
8.2.1. Laser Atherectomy
8.2.2. Orbital Atherectomy
8.2.3. Rotational Atherectomy
8.3. Balloon Catheter
8.3.1. Cutting Balloon Catheter
8.3.2. Drug-Coated Balloon Catheter
8.3.3. Standard Balloon Catheter
8.4. Guidewire
8.4.1. Polymer-Jacketed
8.4.2. PTFE-Coated
8.4.3. Untreated
8.5. Intravascular Imaging System
8.5.1. Fractional Flow Reserve
8.5.2. Intravascular Ultrasound
8.5.3. Optical Coherence Tomography
8.6. Stent
8.6.1. Bare Metal Stent
8.6.2. Bioresorbable Scaffold
8.6.3. Drug Eluting Stent
9. Coronary Artery Disease Treatment Devices Market, by Treatment Type
9.1. Introduction
9.2. Coronary Artery Bypass Grafting
9.2.1. Off Pump
9.2.2. On Pump
9.3. Percutaneous Coronary Intervention
9.3.1. With Balloon Angioplasty
9.3.2. With Stenting
10. Coronary Artery Disease Treatment Devices Market, by Approach
10.1. Introduction
10.2. Transfemoral Approach
10.3. Transradial Approach
11. Coronary Artery Disease Treatment Devices Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Cardiac Centers
11.4. Hospitals
12. Americas Coronary Artery Disease Treatment Devices Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Coronary Artery Disease Treatment Devices Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Coronary Artery Disease Treatment Devices Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Abbott Laboratories
15.3.2. Boston Scientific Corporation
15.3.3. Medtronic plc
15.3.4. Terumo Corporation
15.3.5. Biotronik SE & Co. KG
15.3.6. Lepu Medical Technology (Beijing) Co., Ltd.
15.3.7. Meril Life Sciences Pvt. Ltd.
15.3.8. OrbusNeich Medical Company Limited
15.3.9. MicroPort Scientific Corporation
15.3.10. Cardinal Health, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET MULTI-CURRENCY
FIGURE 2. CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET MULTI-LANGUAGE
FIGURE 3. CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY LASER ATHERECTOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ORBITAL ATHERECTOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ROTATIONAL ATHERECTOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CUTTING BALLOON CATHETER, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DRUG-COATED BALLOON CATHETER, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STANDARD BALLOON CATHETER, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GUIDEWIRE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY POLYMER-JACKETED, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PTFE-COATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY UNTREATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GUIDEWIRE, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY FRACTIONAL FLOW RESERVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BARE METAL STENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BIORESORBABLE SCAFFOLD, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DRUG ELUTING STENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY OFF PUMP, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ON PUMP, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY WITH BALLOON ANGIOPLASTY, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY WITH STENTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TRANSFEMORAL APPROACH, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TRANSRADIAL APPROACH, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GUIDEWIRE, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GUIDEWIRE, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 72. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 73. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2018-2030 (USD MILLION)
TABLE 74. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 75. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GUIDEWIRE, 2018-2030 (USD MILLION)
TABLE 76. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 77. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT, 2018-2030 (USD MILLION)
TABLE 78. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 79. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2030 (USD MILLION)
TABLE 80. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 81. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 82. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 84. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2018-2030 (USD MILLION)
TABLE 85. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 86. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GUIDEWIRE, 2018-2030 (USD MILLION)
TABLE 87. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 88. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT, 2018-2030 (USD MILLION)
TABLE 89. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 90. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2030 (USD MILLION)
TABLE 91. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 92. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 93. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GUIDEWIRE, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GUIDEWIRE, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2018-2030 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GUIDEWIRE, 2018-2030 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 128. UNITED KINGDOM CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2018-2030 (USD MILLION)
TABLE 130. UNITED KINGDOM CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 131. UNITED KINGDOM CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GUIDEWIRE, 2018-2030 (USD MILLION)
TABLE 132. UNITED KINGDOM CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 133. UNITED KINGDOM CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT, 2018-2030 (USD MILLION)
TABLE 134. UNITED KINGDOM CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 135. UNITED KINGDOM CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2030 (USD MILLION)
TABLE 136. UNITED KINGDOM CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 138. UNITED KINGDOM CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. GERMANY CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 140. GERMANY CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2018-2030 (USD MILLION)
TABLE 141. GERMANY CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 142. GERMANY CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GUIDEWIRE, 2018-2030 (USD MILLION)
TABLE 143. GERMANY CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 144. GERMANY CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT, 2018-2030 (USD MILLION)
TABLE 145. GERMANY CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 146. GERMANY CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2030 (USD MILLION)
TABLE 147. GERMANY CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 148. GERMANY CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 149. GERMANY CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. FRANCE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 151. FRANCE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2018-2030 (USD MILLION)
TABLE 152. FRANCE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 153. FRANCE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GUIDEWIRE, 2018-2030 (USD MILLION)
TABLE 154. FRANCE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 155. FRANCE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT, 2018-2030 (USD MILLION)
TABLE 156. FRANCE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 157. FRANCE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2030 (USD MILLION)
TABLE 158. FRANCE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 159. FRANCE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 160. FRANCE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 162. RUSSIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2018-2030 (USD MILLION)
TABLE 163. RUSSIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 164. RUSSIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GUIDEWIRE, 2018-2030 (USD MILLION)
TABLE 165. RUSSIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 166. RUSSIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT, 2018-2030 (USD MILLION)
TABLE 167. RUSSIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 168. RUSSIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2030 (USD MILLION)
TABLE 169. RUSSIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 170. RUSSIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 171. RUSSIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. ITALY CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 173. ITALY CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2018-2030 (USD MILLION)
TABLE 174. ITALY CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 175. ITALY CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GUIDEWIRE, 2018-2030 (USD MILLION)
TABLE 176. ITALY CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 177. ITALY CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT, 2018-2030 (USD MILLION)
TABLE 178. ITALY CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 179. ITALY CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2030 (USD MILLION)
TABLE 180. ITALY CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 181. ITALY CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 182. ITALY CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 183. SPAIN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 184. SPAIN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2018-2030 (USD MILLION)
TABLE 185. SPAIN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 186. SPAIN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GUIDEWIRE, 2018-2030 (USD MILLION)
TABLE 187. SPAIN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 188. SPAIN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT, 2018-2030 (USD MILLION)
TABLE 189. SPAIN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 190. SPAIN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2030 (USD MILLION)
TABLE 191. SPAIN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 192. SPAIN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 193. SPAIN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. UNITED ARAB EMIRATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 195. UNITED ARAB EMIRATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2018-2030 (USD MILLION)
TABLE 196. UNITED ARAB EMIRATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 197. UNITED ARAB EMIRATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GUIDEWIRE, 2018-2030 (USD MILLION)
TABLE 198. UNITED ARAB EMIRATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 199. UNITED ARAB EMIRATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT, 2018-2030 (USD MILLION)
TABLE 200. UNITED ARAB EMIRATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 201. UNITED ARAB EMIRATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2030 (USD MILLION)
TABLE 202. UNITED ARAB EMIRATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 203. UNITED ARAB EMIRATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 204. UNITED ARAB EMIRATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 205. SAUDI ARABIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 206. SAUDI ARABIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2018-2030 (USD MILLION)
TABLE 207. SAUDI ARABIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 208. SAUDI ARABIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GUIDEWIRE, 2018-2030 (USD MILLION)
TABLE 209. SAUDI ARABIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 210. SAUDI ARABIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT, 2018-2030 (USD MILLION)
TABLE 211. SAUDI ARABIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 212. SAUDI ARABIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2030 (USD MILLION)
TABLE 213. SAUDI ARABIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 214. SAUDI ARABIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 215. SAUDI ARABIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 216. SOUTH AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 217. SOUTH AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2018-2030 (USD MILLION)
TABLE 218. SOUTH AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 219. SOUTH AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GUIDEWIRE, 2018-2030 (USD MILLION)
TABLE 220. SOUTH AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 221. SOUTH AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT, 2018-2030 (USD MILLION)
TABLE 222. SOUTH AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 223. SOUTH AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2030 (USD MILLION)
TABLE 224. SOUTH AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 225. SOUTH AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 226. SOUTH AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. DENMARK CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 228. DENMARK CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2018-2030 (USD MILLION)
TABLE 229. DENMARK CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 230. DENMARK CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GUIDEWIRE, 2018-2030 (USD MILLION)
TABLE 231. DENMARK CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 232. DENMARK CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT, 2018-2030 (USD MILLION)
TABLE 233. DENMARK CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 234. DENMARK CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2030 (USD MILLION)
TABLE 235. DENMARK CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 236. DENMARK CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 237. DENMARK CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 238. NETHERLANDS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 239. NETHERLANDS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2018-2030 (USD MILLION)
TABLE 240. NETHERLANDS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 241. NETHERLANDS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GUIDEWIRE, 2018-2030 (USD MILLION)
TABLE 242. NETHERLANDS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 243. NETHERLANDS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT, 2018-2030 (USD MILLION)
TABLE 244. NETHERLANDS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 245. NETHERLANDS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2030 (USD MILLION)
TABLE 246. NETHERLANDS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 247. NETHERLANDS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 248. NETHERLANDS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 249. QATAR CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 250. QATAR CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2018-2030 (USD MILLION)
TABLE 251. QATAR CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 252. QATAR CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GUIDEWIRE, 2018-2030 (USD MILLION)
TABLE 253. QATAR CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 254. QATAR CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT, 2018-2030 (USD MILLION)
TABLE 255. QATAR CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 256. QATAR CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2030 (USD MILLION)
TABLE 257. QATAR CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 258. QATAR CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 259. QATAR CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 260. FINLAND CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 261. FINLAND CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2018-2030 (USD MILLION)
TABLE 262. FINLAND CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 263. FINLAND CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GUIDEWIRE, 2018-2030 (USD MILLION)
TABLE 264. FINLAND CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 265. FINLAND CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT, 2018-2030 (USD MILLION)
TABLE 266. FINLAND CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 267. FINLAND CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2030 (USD MILLION)
TABLE 268. FINLAND CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 2

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Coronary Artery Disease Treatment Devices market report include:
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Medtronic plc
  • Terumo Corporation
  • Biotronik SE & Co. KG
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Meril Life Sciences Pvt. Ltd.
  • OrbusNeich Medical Company Limited
  • MicroPort Scientific Corporation
  • Cardinal Health, Inc.

Table Information

Report AttributeDetails
No. of Pages193
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 4.84 Billion
Forecasted Market Value ( USD ) by 2030 $ 6.41 Billion
Compound Annual Growth Rate5.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Interventional Cardiology Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Interventional Cardiology Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Embolic Protection Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Embolic Protection Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Percutaneous Coronary Intervention (PCI) Devices - Global Strategic Business Report - Product Image

Percutaneous Coronary Intervention (PCI) Devices - Global Strategic Business Report

  • Report
  • 193 Pages
  • Global
From
Global Drug-Coated Balloons Market - Focused Insights 2024-2029 - Product Image

Global Drug-Coated Balloons Market - Focused Insights 2024-2029

  • Report
  • 133 Pages
  • Global
From
Coronary Atherectomy Devices Market Report 2025 - Product Image

Coronary Atherectomy Devices Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.